Annual report pursuant to Section 13 and 15(d)

SEGMENT REPORTING (Tables)

v3.22.1
SEGMENT REPORTING (Tables)
 12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table is a comparative summary of the Company’s net sales and segment profit for by reportable segment for the periods presented:
Year ended
  December 31,
2021		 December 31,
2020
Segment Net Sales:
Cannabinoid $ 3,242  $ 2,511 
Non-Cannabinoid 12,132  9,606 
Total Net Sales 15,374  12,117 
 
Segment Profit (Loss):
Cannabinoid (16,915) (18,798)
Non-Cannabinoid 2,631  1,863 
Total Loss $ (14,284) $ (16,935)
 
Reconciliation:
Total Segment Loss (14,284) (16,935)
Unallocated corporate expenses (11,196) (6,405)
Non-cash share based compensation (11,451) (1,652)
Depreciation and amortization (1,768) (1,854)
Goodwill impairment (18,508) (1,682)
Loss from operations $ (57,207) $ (28,528)
 
(Gain) loss on debt extinguishment, net (3,262) 2,360 
Gain on remeasurement of warrant liability (16,856) (10,780)
Loss on fair value of derivative instrument —  657 
Loss on investments —  464 
Foreign exchange loss 1,276  491 
Interest expense 6,818  4,455 
Other income, net (502) (284)
Loss from operations before income taxes and equity investment loss $ (44,681) $ (25,891)
During 2021 and 2020, the Company's net sales for the non-cannabinoid segment were in the U.S; cannabinoid net sales were mostly outside of the U.S., primarily in Colombia, Israel, Brazil and Australia.
December 31,
2021		 December 31,
2020
Long-lived assets
   
Cannabinoid $ 30,709  $ 25,485 
Non-Cannabinoid
216  176 
Other(a)
7  19 
  $ 30,932  $ 25,680 
____________
(a)“Other” includes long-lived assets primarily in the Company’s corporate offices.
Schedule of Revenue by Major Customers by Reporting Segments Customers with an accounts receivable balance of 10% or greater of total accounts receivable and customers with net revenue of 10% or greater of total revenues are presented below for the periods indicated:
Percentage of Revenues Percentage of Accounts Receivable
December 31, December 31,
2021 2020 2021 2020
Customer A (a)
* * * 40%
Customer B (a)
* * * 23%
Customer C (b)
17  % 21  % 25% 11%
Customer D (a)
* * 18% *
* denotes less than 10%

(a) net sales attributed are reflected in the cannabinoid segments
(b) net sales attributed are reflected in the non-cannabinoid segments
Disaggregation of Revenue by Channel
The following table disaggregates the Company’s revenues by channel for the for the periods presented:
  Year ended
  December 31,
2021		 December 31,
2020
Mass retail $ 8,070  $ 6,879 
Distributors 5,835  4,036 
Specialty, health and other retail 945  689 
E-commerce 524  513 
$ 15,374  $ 12,117